Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol-Reference-Cited by-同舟云学术

Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol

Published:2017-07 Issue:7 Volume:7 Page:e016738
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Bally Lia,Thabit Hood,Tauschmann Martin,Allen Janet M,Hartnell Sara,Wilinska Malgorzata E,Exall Jane,Huegel Viki,Sibayan Judy,Borgman Sarah,Cheng Peiyao,Blackburn Maxine,Lawton Julia,Elleri Daniela,Leelarathna Lalantha,Acerini Carlo L,Campbell Fiona,Shah Viral N,Criego Amy,Evans Mark L,Dunger David B,Kollman Craig,Bergenstal Richard M,Hovorka Roman

Funder

National Institute for Health Research Cambridge Biomedical Research Centre

JDRF

Wellcome Strategic Award

Publisher

BMJ

Subject

General Medicine

Reference26 articles.

1. Type 1 diabetes;Atkinson;Lancet,2014

2. International Diabetes Federation. Diabetes Atlas. 72015, 2016. http://www.diabetesatlas.org/ (last accessed 24 March 2016).

3. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences;Home;Diabetes Obes Metab,2012